BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190520
DTEND;VALUE=DATE:20190524
DTSTAMP:20260514T223727
CREATED:20190213T092120Z
LAST-MODIFIED:20190214T153920Z
UID:19511-1558310400-1558655999@www.pharmajournalist.com
SUMMARY:TIDES: Oligonucleotide & Peptide Therapeutics
DESCRIPTION:TIDES is the world’s largest meeting to accelerate oligonucleotide and peptide products from early discovery to late-stage development & commercialization. \n \n1000+ Oligonucleotide & Peptide Scientists and Executives\nFast-track your oligonucleotide and peptide research to the clinic and beyond by collaborating with leading pharma\, biotechs\, academia and solution providers from North America\, Asia and Europe. \n90+ Exhibitors\nConnect with leading manufacturing\, technologies\, and service providers to drive your promising therapeutic towards commercial success. \n125+ Case Studies and New Data Presentations\nHear best practices\, lessons learned and important industry developments across the entire spectrum of oligonucleotide and peptide development and production. \nRegister now at www.TIDESEvent.com with code “PHARMJ10” and SAVE 10%.
URL:https://www.pharmajournalist.com/event/tides-oligonucleotide-peptide-therapeutics/
LOCATION:Manchester Grand Hyatt | San Diego\, CA
ORGANIZER;CN="Knect365 Life Sciences":MAILTO:Allison.macdonald@knect365.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190521
DTEND;VALUE=DATE:20190524
DTSTAMP:20260514T223727
CREATED:20190206T125335Z
LAST-MODIFIED:20190206T125335Z
UID:19387-1558396800-1558655999@www.pharmajournalist.com
SUMMARY:NDD Europe 2019
DESCRIPTION:Overcome Translational Challenges Preventing the Development of Clinically Effective Neurodegenerative Therapeutics \n \nMultiple clinical failures in the neurodegenerative field have sparked realisation that there is a critical need for discussion and debate between neurodegenerative drug developers to drive clinical success. \nNDD Europe will overcome the translational challenges facing neurodegenerative drug developers by exploring the future biomarkers of neurodegeneration\, improving preclinical modelling to increase clinical predictability and encouraging precompetitive strategies and collaboration amongst drug developers. \nWith 70+ thought-leaders converging at NDD Europe\, this will be an unrivalled opportunity for you to gain the latest scientific insights\, have your peers review your research and grow your collaborator network.
URL:https://www.pharmajournalist.com/event/ndd-europe-2019/
LOCATION:Hilton Paris La Defense\, 2 Place de la Défense\, 92800\, Puteaux\, France\, France
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190521
DTEND;VALUE=DATE:20190524
DTSTAMP:20260514T223727
CREATED:20190404T072211Z
LAST-MODIFIED:20190404T072453Z
UID:20182-1558396800-1558655999@www.pharmajournalist.com
SUMMARY:5th Precision CRISPR Genome Editing Congress
DESCRIPTION:Designed with CRISPR experts from AstraZeneca\, AbbVie\, Broad Institute\, Casebia\, Merck\, Amgen and academics worldwide\, this years 5th Precision CRISPR Genome Editing Congress encapsulates the critical scientific challenges and opportunities of CRISPR applications with regards to delivery\, safety\, precision\, and efficiency to further optimize the relevant areas of drug discovery\, functional screening & CRISPR-based cell & gene therapy. \n \n\nLearn about how CRISPR is working in a clinical setting and unique approaches to gene therapy\nDiscover advances in disease modeling and strategies improving validation of human biology\nUnderstand how we are harnessing novel CRISPR systems and the resulting expansion of the molecular toolbox\nExplore how base editing is set to be the best technique for precision genome editing and the consequent applications in both basic biology and genetic diseases\nDiscover the wealth of CRISPR screening techniques available and how to implement them into your own drug discovery pipeline\nParticipate in forward-thinking debates and discussions crucial to advancing the infinite possibilities of CRISPR\n\nWith 100+ thought-leaders converging\, this will surely be an unrivaled opportunity for you to gain the latest scientific insights into the ever-evolving CRISPR landscape and grow your collaborator network. \nTo learn more about this event\, visit https://ter.li/tjkmgn
URL:https://www.pharmajournalist.com/event/5th-precision-crispr-genome-editing-congress/
LOCATION:The Westin Boston Waterfront\, 425 Summer Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190523
DTEND;VALUE=DATE:20190525
DTSTAMP:20260514T223727
CREATED:20190118T101935Z
LAST-MODIFIED:20190118T101935Z
UID:19147-1558569600-1558742399@www.pharmajournalist.com
SUMMARY:RE•WORK Deep Learning in Healthcare Summit\, Boston
DESCRIPTION:The Deep Learning in Healthcare Summit is returning to the east coast for the annual event in Boston! Hear from healthcare industry leaders\, academics\, researchers\, and innovative startups working to advance deep learning technology and apply this within the health sector. Focusing on topics such as medical imaging\, diagnostics\, personalized medicine and how these are applied within pharmaceuticals\, patient care\, and health and wellbeing. The summit is a great way to discover the latest insights\, evaluate your position within the industry and learn how the impacts can affect yourself and your work and provides an opportunity to network with other valued members of the community. \nDiscount Code: MP20 
URL:https://www.pharmajournalist.com/event/re%e2%80%a2work-deep-learning-in-healthcare-summit-boston/
LOCATION:InterContinental® Boston\, 510 Atlantic Avenue\, Massachusetts 02210
ORGANIZER;CN="RE%E2%80%A2WORK":MAILTO:luke@re-work.co
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190523
DTEND;VALUE=DATE:20190524
DTSTAMP:20260514T223727
CREATED:20190213T123725Z
LAST-MODIFIED:20190213T124118Z
UID:19536-1558569600-1558655999@www.pharmajournalist.com
SUMMARY:Microbiome Invest
DESCRIPTION:Microbiome Invest 2019 is dedicated to showcasing the most innovative emerging companies and academics with commercially viable research that manipulates the microbiome. Active investors\, and multi-national nutrition and pharmaceutical companies will also share their knowledge and perspectives on commercialisation and discuss the most cutting-edge products and research in the microbiome space.
URL:https://www.pharmajournalist.com/event/microbiome-invest-2/
LOCATION:London (Venue TBC)
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
END:VCALENDAR